Cargando…
Brain endothelial cell‐targeted gene therapy of neurovascular disorders
Neurovascular disorders are difficult to treat due to the blood–brain barrier (BBB), which prevents delivery of most drugs from the blood into the brain. Gene therapy can potentially overcome this barrier, but classical vectors are neither efficient nor specific enough to provide long‐lasting treatm...
Autores principales: | Marchiò, Serena, Sidman, Richard L, Arap, Wadih, Pasqualini, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888850/ https://www.ncbi.nlm.nih.gov/pubmed/27189170 http://dx.doi.org/10.15252/emmm.201606407 |
Ejemplares similares
-
Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy
por: Dondossola, Eleonora, et al.
Publicado: (2014) -
Does the RAAS play a role in loss of taste and smell during COVID-19 infections?
por: Luchiari, Heloise R., et al.
Publicado: (2020) -
Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction
por: Li, Jianxue, et al.
Publicado: (2020) -
Binding brain better—matching var genes and endothelial receptors
por: Fleckenstein, Hannah, et al.
Publicado: (2019) -
Vascular Targeting: Recent Advances and Therapeutic Perspectives
por: Hajitou, Amin, et al.
Publicado: (2006)